Mikhail Blagosklonny and Andrei V. Gudkov of Roswell Park Cancer Institute laid the foundation stone for the renowned Oncotarget journal back in 2010. It is now a weekly open access peer-reviewed medical journal catering to the needs, know-how and ongoing researches in the field of oncology. Ever since they began publishing, oncotarget has published more than three hundred and seventy papers on topics of oncology on impactjournals.com. William G. Kaelin and Gregg L Semenza have contributed more than seven articles that deal with oxygen. They have both been recognized by Lasker Awards for the discovery of the oxygen sensing pathway.
The journal is about facilitating the want and need of the latest happenings in the scientific research industry on impactjournals.com. This information was not easily available before the Oncotarget era. This year, they announced that they would include citations for areas beyond oncology. gerotarget or ageing, microbiology, immunology, neuropathology, neuroscience, endocrinology, cardiology, metabolism, cell biology, molecular biology and Pharmacology are among the categories to be included.
With the kind of determination and the resources pumped into the adventure, all the medical practitioners who are involved in research are bound to acquire a big pool of information in one platform. Andrei V. Gudkov and Mikhail Blagosklonny have always been on the forefront of championing free medical journalism as this would increase the chances of new discoveries. Oncotarget reduces the efforts of the concerned individuals hence they can concentrate more on achieving their goals.
Oncotarget vision is “life without diseases” and their researchers are well motivated that this is achievable. They have acted as a benchmark for future medical research on gettingstronger.org. The number of publications has increased exponentially year after year with their editorial team being feted at different levels.
A real-time tracking called ‘Free Altmetric Article reports’ have been started to ensure that all the published articles are monitored. Both digital and traditional materials are followed even before citation begins; this guarantees that a researcher like Mikhail Blagosklonny will have multiple help to aid research.
Mikhail Blagosklonny expect that this project will lead to a reduction in specialized treatment charges thus achieving their mission of a world without diseases.